AJANTA PHARMA PHILIPPINES INC — Pioglitazone Importer Profile
Pharmaceutical Importer · #8 buyer for Pioglitazone · $735.9K import value · 16 shipments · PHILIPPINES · DGFT Verified
AJANTA PHARMA PHILIPPINES INC is the #8 importer of Pioglitazone from India with $735.9K in import value and 16 verified shipments. AJANTA PHARMA PHILIPPINES INC holds a 2.1% market share in Pioglitazone imports based in PHILIPPINES. The company sources from 1 verified supplier across 14 formulations shipped to 1 country. Overall, AJANTA PHARMA PHILIPPINES INC imports 7 pharmaceutical products worth $5.3M across 5 therapeutic categories.
AJANTA PHARMA PHILIPPINES INC — Pioglitazone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Pioglitazone to AJANTA PHARMA PHILIPPINES INC?
Verified from 16 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AJANTA PHARMA LIMITED | $735.9K | 16 | 100.0% |
AJANTA PHARMA PHILIPPINES INC sources Pioglitazone from 1 verified Indian supplier based on 16 customs records. The primary supplier is AJANTA PHARMA LIMITED accounting for 100.0% of imports.
How Does AJANTA PHARMA PHILIPPINES INC Compare to Nearest Pioglitazone Importers?
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | MACLEODS PHARMA USA INC | UNITED STATES | $896.9K | 74 | $12.1K |
| 11 | MACLEODS PHARMA USA,INC | UNITED STATES | $878.3K | 47 | $18.7K |
| 8 | AJANTA PHARMA PHILIPPINES INC ★ | PHILIPPINES | $800.0K | 16 | $50.0K |
| 12 | RISING PHARMA HOLDINGS, INC. , | UNITED STATES | $657.5K | 32 | $20.5K |
| 13 | AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $601.5K | 59 | $10.2K |
AJANTA PHARMA PHILIPPINES INC ranks #8 among 293 Pioglitazone importers from India. Average shipment value of $50.0K compared to the market average of $71.8K. The closest competitors by value are MACLEODS PHARMA USA INC and MACLEODS PHARMA USA,INC.
Where Does AJANTA PHARMA PHILIPPINES INC Import Pioglitazone To?
Destination countries from 16 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $735.9K | 16 | 100.0% |
AJANTA PHARMA PHILIPPINES INC imports Pioglitazone to 1 country. The primary destination is PHILIPPINES receiving 100.0% of shipments worth $735.9K.
What Pioglitazone Formulations Does AJANTA PHARMA PHILIPPINES INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| ASENZA PLUS 15/2 MG TABLETS[12600PACKx3x10=378000TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV | $100.0K | 2 |
| ASENZA PLUS 30/2 MG TABLETS[12060PACKx3x10=361800TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV | $100.0K | 2 |
| ASENZA PLUS 30/2 MG TABS[12960PACKx3x10=388800 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TAB CONT:AS PER INV | $50.0K | 1 |
| ASENZA PLUS 15/2 MG TABS[13020PACKx3x10=390600TABS][PIOGLITAZONE AND GLIMEPIRIDETABS]EACH UNCOATED TABS CONT:AS PER INV | $50.0K | 1 |
| ASENZA PLUS 30/2 MG TABS[12595PACKx3x10=377850 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS] [EACH UNCOATED TABLET AS PER INV | $50.0K | 1 |
| ASENZA PLUS 15/2 MG TABS[12295PACKx3x10=368850 TABS][PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TABS CONT:AS PER INV | $50.0K | 1 |
| TENELIZONE TABLETS 20/30 MG [12840 PACKX3X10=385200 TABS](TENELIGLIPTIN 20MG & PIOGLITAZONE 30MG TABLETS) AS PER INVOICENOS | $50.0K | 1 |
| ASENZA PLUS 30/2 MG TABLETS[12765PACKX3X10=382950 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TABS AS PER INV | $50.0K | 1 |
| ASENZA PLUS 15/2 MG TABS[12825PACKX3X10=384750 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TAB CONT:AS PER INV | $50.0K | 1 |
| ASENZA PLUS 30/2 MG TABLETS[12655PACKx3x10=379650 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TAB AS PER INV | $50.0K | 1 |
AJANTA PHARMA PHILIPPINES INC imports 14 distinct Pioglitazone formulations from India. The top formulation is ASENZA PLUS 15/2 MG TABLETS[12600PACKx3x10=378000TABS]PIOGLI with 2 shipments worth $100.0K.
Who Are the Top Buyers of Pioglitazone from India and How Much Does AJANTA PHARMA PHILIPPINES INC Import?
India exported $21.0M worth of Pioglitazone through 2,674 shipments from 115 suppliers to 70 countries, serving 293 buyers globally. AJANTA PHARMA PHILIPPINES INC imports $735.9K of this total, accounting for 2.1% of India's Pioglitazone exports with 16 shipments from PHILIPPINES. This is verified from 16 customs shipment records covering 14 distinct formulations.
What Is the Average Order Value for AJANTA PHARMA PHILIPPINES INC's Pioglitazone Imports?
AJANTA PHARMA PHILIPPINES INC's average Pioglitazone order value is $46.0K per consignment, based on 16 shipments totaling $735.9K. AJANTA PHARMA PHILIPPINES INC is based in PHILIPPINES and ranks #8 among all Pioglitazone importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Pioglitazone to AJANTA PHARMA PHILIPPINES INC?
AJANTA PHARMA PHILIPPINES INC sources Pioglitazone from 1 verified Indian supplier: AJANTA PHARMA LIMITED ($735.9K, 100.0%). This is based on 16 customs records.
How Does AJANTA PHARMA PHILIPPINES INC Compare to Other Pioglitazone Importers?
AJANTA PHARMA PHILIPPINES INC ranks #8 among 293 Pioglitazone importers from India with a 2.1% market share. The top 3 importers are RISING PHARMA HOLDINGS, INC. ,. ($2.8M), RISING PHARMA HOLDINGS, INC. ($2.6M), AUROLOGISTICS LLC (AUROBINDO PHARMA ($2.4M). AJANTA PHARMA PHILIPPINES INC processed 16 shipments from PHILIPPINES.
What Other Diabetes & Endocrine Products Does AJANTA PHARMA PHILIPPINES INC Import?
AJANTA PHARMA PHILIPPINES INC also imports these diabetes & endocrine products. Each links to the detailed product page.
About AJANTA PHARMA PHILIPPINES INC
AJANTA PHARMA PHILIPPINES INC imports 7 products worth $5.3M. Beyond Pioglitazone, top products include Febuxostat, Cetirizine, Montelukast, Glimepiride, Fenofibrate. View the complete AJANTA PHARMA PHILIPPINES INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pioglitazone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pioglitazone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AJANTA PHARMA PHILIPPINES INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AJANTA PHARMA PHILIPPINES INC's capped import value divided by total capped export value for Pioglitazone across all Indian exporters.
- 5.Verified Records: This page is backed by 16 individual customs records matching AJANTA PHARMA PHILIPPINES INC importing Pioglitazone, covering 14 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 70+ countries, 293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pioglitazone Import Data for AJANTA PHARMA PHILIPPINES INC
Access order-level details, pricing data, supplier connections, and competitive analysis for AJANTA PHARMA PHILIPPINES INC's Pioglitazone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AJANTA PHARMA PHILIPPINES INC
Full Company Profile →
7 products · $5.3M total trade · 5 categories
AJANTA PHARMA PHILIPPINES INC × Pioglitazone
Verified from customs records
Company Overview
Top Products by AJANTA PHARMA PHILIPPINES INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AJANTA PHARMA PHILIPPINES INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pioglitazone. For current order-level data, contact TransData Nexus.